Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Accumulated Expenses (2021 - 2025)

Updated

Raphael Pharmaceutical (RAPH) reported Accumulated Expenses of $343,000 for Q4 2025, down 8.5% from $375,000 a year earlier.

Analysis

Raphael Pharmaceutical (RAPH) Accumulated Expenses (2021 - 2025) Analysis & Trends

Dating back to Q4 2021, Raphael Pharmaceutical's Accumulated Expenses record includes 5 quarters.

  • Accumulated Expenses has a four-year compound annual growth rate of 20.1% (FY2021 to FY2025).
  • By year, Accumulated Expenses came in at $375,000 in FY2024, $25,000 in FY2023 (-83.6%), $152,000 in FY2022 (-7.9%) and $165,000 in FY2021.
  • The Q4 2025 figure ranks as the lowest quarterly Accumulated Expenses since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Raphael Pharmaceutical 28.25 Mn 28.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 343,000.00
Dec 31, 2024 375,000.00
Dec 31, 2023 25,000.00
Dec 31, 2022 152,000.00
Dec 31, 2021 165,000.00
API Access

Raphael Pharmaceutical Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RAPH&period=max&api_key=YOUR_API_KEY